Ariad Pharmaceuticals Inc fka ARIA

[Whosetosay]

Thinking out loud, there has to be 600 patients on the drug by now, or there abouts, and some of them may have a neuro disease on which Ponatinib may have a positive effect.

Might we hear about that? If we see scans of tumors disappearing in a patient, a startling effect on the improvement of a neuro condition, above whatever effect a concurrent medication might provide, could be just as telling, no?